• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    3/5/24 1:11:47 PM ET
    $AIMD
    $AISP
    $ALB
    $APGE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $AIMD alert in real time by email

    Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

    Sophia Genetics posted GAAP loss of 37 cents per share, versus market expectations for a loss of 27 cents per share. The company’s quarterly sales came in at $17.05 million, missing estimates of $17.33 million.

    SOPHiA GENETICS shares tumbled 19% to $4.55 on Tuesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) climbed 146.3% to $0.1106 after dipping 19% on Monday. Sunshine Biopharma recently announced closing of $10.0 million underwritten public offering.
    • Airship AI Holdings, Inc. (NASDAQ:AISP) climbed 93.3% to $3.16 after the company announced that it has been awarded a contract with the Department of Justice for its Acropolis Enterprise Sensor Management video and data management platform.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) surged 42.9% to $0.0686.
    • Apogee Therapeutics, Inc. (NASDAQ:APGE) shares jumped 41.6% to $59.10 after the company announced interim results from its Phase 1 healthy volunteer trial for APG777. Also, the company reported FY23 financial results.
    • Dave Inc. (NASDAQ:DAVE) gained 39.8% to $30.62 after the company reported a year-over-year increase in fourth-quarter revenue results.
    • CareMax, Inc. (NASDAQ:CMAX) rose 38.1% to $10.65.
    • Enviva Inc. (NYSE:EVA) gained 26.4% to $0.6571.
    • AeroVironment, Inc. (NASDAQ:AVAV) shares surged 24.8% to $163.05 after the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 adjusted earnings of $2.69 to $2.83 per share on revenue of $700 million to $710 million.
    • INNOVATE Corp. (NASDAQ:VATE) rose 24.4% to $0.90. The company reported fourth quarter financial results.
    • Ocean Biomedical, Inc. (NASDAQ:OCEA) climbed 24.3% to $5.07.
    • Paymentus Holdings, Inc. (NYSE:PAY) rose gained 20.3% to $19.67 after the company reported better-than-expected fourth quarter financial results.
    • BeyondSpring Inc. (NASDAQ:BYSI) gained 20.1% to $1.97.
    • bioAffinity Technologies, Inc. (NASDAQ:BIAF) climbed 19.4% to $2.83. bioAffinity Technologies reported accelerating sales growth of CyPath® Lung.
    • XORTX Therapeutics Inc. (NASDAQ:XRTX) gained 18.4% to $4.18.
    • Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) rose 17.9% to $1.52 after the company announced that the U.S. Patent and Trademark Office issued a notice of allowance for U.S. Application No. 17,857,723 Titled Compositions And Methods For Detecting Predisposition To Cardiovascular Disease.
    • Phunware, Inc. (NASDAQ:PHUN) shares rose 17.2% to $14.56. Phunware shares jumped 75% on Monday amid volatility in Trump-related stocks after Donald Trump won the Missouri and Idaho Republican caucuses. Also, the Supreme Court ruled that Colorado can't remove Donald Trump from the Republican primary ballot in the state.
    • 3D Systems Corporation (NYSE:DDD) jumped 14.7% to $4.7150. 3D Systems announced additional partial repurchase of convertible senior notes.
    • Fresenius Medical Care AG (NYSE:FMS) gained 12.2% to $20.95. Fresenius Medical Care achieved next milestone in portfolio optimization program, announcing sale of dialysis clinics in Brazil, Colombia, Chile, Ecuador.
    • New York Community Bancorp, Inc. (NASDAQ:NYCB) gained 11.3% to $3.0411 after falling 23% on Monday. New York Community Bancorp last week announced that it identified material weaknesses in its internal controls and replaced its CEO.
    • Vicarious Surgical Inc. (NYSE:RBOT) rose 7.8% to $0.3880 after the company reported quarterly financial results.
    • DaVita Inc. (NYSE:DVA) gained 7.4% to $135.14. DaVita entered into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador.
    • Momentus Inc. (NASDAQ:MNTS) shares rose 7% to $0.8345 after the company was awarded a contract from NASA.

    Losers

    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares fell 46.2% to $1.56 after the company announced the pricing of a $6.5 million public offering.
    • Crawford & Company (NYSE: CRD-A) fell 27.7% to $9.04 after the company reported worse-than-expected fourth-quarter financial results.
    • Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) fell 24.8% to $1.58 after the company reported mixed fourth-quarter financial results.
    • ThredUp Inc. (NASDAQ:TDUP) fell 23.3% to $1.8099 after reporting fourth-quarter results.
    • Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) fell 22.5% to $0.7909. Lipella Pharmaceuticals announced FDA clearance of IND for LP-410 for oral graft-versus-host disease, advancing clinical pipeline.
    • Kineta, Inc. (NASDAQ:KA) fell 21% to $0.7983.
    • Eyenovia, Inc. (NASDAQ:EYEN) dipped 21% to $1.8006.
    • Semrush Holdings, Inc. (NYSE:SEMR) fell 19.9% to $10.42 after the company reported fourth-quarter financial results.
    • BitFuFu Inc. (NASDAQ:FUFU) fell 19.3% to $10.60. BitFuFu shares jumped around 106% on Monday amid volatility following the company's recent business combination with Arisz Acquisition Corp and listing on the Nasdaq.
    • GitLab Inc. (NASDAQ:GTLB) shares fell 19.2% to $60.16 after the company issued FY25 earnings guidance below estimates.
    • Sidus Space, Inc. (NASDAQ:SIDU) declined 19.2% to $4.58.
    • Yiren Digital Ltd. (NYSE:YRD) fell 16.3% to $4.60.
    • Cara Therapeutics, Inc. (NASDAQ:CARA) fell 16.2% to $0.8375 following downbeat fourth-quarter results.
    • Stitch Fix, Inc. (NASDAQ:SFIX) shares dipped 15.7% to $2.7650 after the company reported worse-than-expected second-quarter financial results and issued a weak revenue forecast for FY24.
    • Lotus Technology Inc. (NASDAQ:LOT) fell 15.6% to $5.66.
    • Zhongchao Inc. (NASDAQ:ZCMD) fell 13.8% to $ 2.73.
    • CECO Environmental Corp. (NASDAQ:CECO) dipped 13.8% to $19.74 despite better-than-expected fourth-quarter financial results and raised guidance.
    • Renalytix Plc (NASDAQ:RNLX) shares declined 13.5% to $1.27. Renalytix shares jumped 41% on Monday after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company.
    • Powell Industries, Inc. (NASDAQ:POWL) tumbled 12.4% to $161.88.
    • Vivakor, Inc. (NASDAQ:VIVK) shares fell 12.3% to $0.93 after jumping around 30% on Monday. Vivakor signed a definitive merger agreement with Empire Diversified Energy for a combined enterprise value of approximately $250 million.
    • MicroStrategy Incorporated (NASDAQ:MSTR) shares declined 12.1% to $1,172.93 after the company announced a proposed private offering of $600 million of convertible senior notes.
    • AxoGen, Inc. (NASDAQ:AXGN) fell 12.1% to $9.31 following fourth-quarter financial results.
    • MingZhu Logistics Holdings Limited (NASDAQ:YGMZ) shares fell 11.2% to $0.4785 after gaining over 12% on Monday. MingZhu Logistics Holdings signed a non-binding letter of intent (LOI) to acquire driverless auto technologies and intellectual property (IP) portfolio valued between $80 million and $90 million.
    • Albemarle Corporation (NYSE:ALB) shares fell 11.9% to $117.40 after the company announced a proposed public offering of depositary shares.
    • Tandem Diabetes Care, Inc. (NASDAQ:TNDM) dipped 11% to $27.73 after the company announced a proposed $250 million private placement of convertible notes due 2029.
    • Amer Sports, Inc. (NYSE:AS) fell 10.1% to $15.59 after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued FY24 EPS guidance below estimates.
    • Ainos, Inc. (NASDAQ:AIMD) shares fell 9.8% to $1.28 after surging 35% on Monday.
    • Samsara Inc. (NYSE:IOT) fell 9% to $32.65.
    • MongoDB, Inc. (NASDAQ:MDB) fell 8.2% to $ 402.84.
    • Sprout Social, Inc. (NASDAQ:SPT) fell 8% to $58.96.
    • e.l.f. Beauty, Inc. (NYSE:ELF) declined 7.5% to $193.29.

     

    Now Read This: Top 5 Materials Stocks That Are Ticking Portfolio Bombs

    Get the next $AIMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIMD
    $AISP
    $ALB
    $APGE

    CompanyDatePrice TargetRatingAnalyst
    Tandem Diabetes Care Inc.
    $TNDM
    3/19/2026$35.00Hold → Buy
    Truist
    Apogee Therapeutics Inc.
    $APGE
    3/18/2026$83.00Hold
    Truist
    Tandem Diabetes Care Inc.
    $TNDM
    3/17/2026$33.00Neutral → Overweight
    Piper Sandler
    AeroVironment Inc.
    $AVAV
    3/11/2026$450.00 → $400.00Buy
    Needham
    Strategy Inc
    $MSTR
    3/10/2026$175.00Buy
    B. Riley Securities
    Samsara Inc.
    $IOT
    3/6/2026$40.00 → $44.00Outperform
    BMO Capital Markets
    MongoDB Inc.
    $MDB
    3/5/2026$310.00Sector Perform → Sector Outperform
    Scotiabank
    GitLab Inc.
    $GTLB
    3/4/2026$28.00Overweight → Neutral
    Piper Sandler
    More analyst ratings

    $AIMD
    $AISP
    $ALB
    $APGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026

    SAN FRANCISCO and BOSTON, March 22, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (NASDAQ:APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today announced it will report Part A 52-week data from the Phase 2 APEX trial of zumilokibart on Monday, March 23, 2026. Following the announcement, the company will host a conference call and webcast at 8:00 a.m. ET to discuss the results. Webcast DetailsApogee Therapeutics' live webcast of the Phase 2 APEX Part A results will begin on Monday, March 23rd at 8:00 a.m. ET. The live webcast can be accessed via this l

    3/22/26 7:51:54 PM ET
    $APGE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CECO Environmental and Thermon to Host Joint CEO Fireside Chat at Upcoming Roth Conference

    ADDISON, Texas, March 20, 2026 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (NASDAQ:CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, and Thermon Group Holdings, Inc. (NYSE:THR), a diversified industrial technology company and global leader in industrial process heating solutions, today announces that a joint fireside chat with both CEOs will be held at the 38th Annual Roth Conference on Monday, March 23, 2026 at 4:00 PM PDT. The webcast will be available on the Investor Relations section of both Company's websites www.cecoenviro.com and www.thermon.com. ABOUT CECO ENVIRONMENTALCECO Environme

    3/20/26 5:00:00 PM ET
    $CECO
    $THR
    Pollution Control Equipment
    Industrials
    Industrial Machinery/Components
    Energy

    Phunware Reports Fourth Quarter and Full Year 2025 Financial Results

    Evolution to Focus on Hospitality and Related Markets, Steady Product Revenue, Customer Growth and Expanding Leadership Team Exits FY25 with Strong Cash Position to Accelerate AI Platform and Products and New Corporate Initiatives AUSTIN, Texas, March 20, 2026 (GLOBE NEWSWIRE) -- Phunware, Inc. ("Phunware" or the "Company") (NASDAQ:PHUN), the enterprise cloud platform for mobile-first software products, solutions, data, and services to enable customers to engage, manage, and monetize their global audiences, today reported financial results for the fourth quarter and year ended December 31, 2025. Financial Highlights Net revenue increased 33% to $0.8 million in Q4 2025, as compared to $

    3/20/26 8:05:00 AM ET
    $PHUN
    EDP Services
    Technology

    $AIMD
    $AISP
    $ALB
    $APGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Beilman Kyle

    4 - Dave Inc./DE (0001841408) (Issuer)

    3/20/26 9:00:03 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Jones Jason C

    4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)

    3/20/26 7:05:29 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Wong Jerome

    4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)

    3/20/26 7:03:57 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    $AIMD
    $AISP
    $ALB
    $APGE
    SEC Filings

    View All

    SEC Form PREM14C filed by Ekso Bionics Holdings Inc.

    PREM14C - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)

    3/20/26 5:13:51 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    SEC Form 20-F filed by XORTX Therapeutics Inc.

    20-F - XORTX Therapeutics Inc. (0001729214) (Filer)

    3/20/26 5:00:56 PM ET
    $XRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Zhongchao Inc.

    6-K - Zhongchao Inc. (0001785566) (Filer)

    3/20/26 4:00:18 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    $AIMD
    $AISP
    $ALB
    $APGE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Nakache Patricia bought $49,076 worth of shares (13,157 units at $3.73) (SEC Form 4)

    4 - ThredUp Inc. (0001484778) (Issuer)

    3/10/26 6:24:14 PM ET
    $TDUP
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Farrell Matthew bought $464,814 worth of shares (5,000 units at $92.96), increasing direct ownership by 86% to 10,820 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    2/23/26 4:07:34 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    Large owner Asher Daniel bought $191,162 worth of shares (15,540 units at $12.30) (SEC Form 4)

    4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)

    2/20/26 4:57:37 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    $AIMD
    $AISP
    $ALB
    $APGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tandem Diabetes Care upgraded by Truist with a new price target

    Truist upgraded Tandem Diabetes Care from Hold to Buy and set a new price target of $35.00

    3/19/26 8:24:11 AM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    Truist initiated coverage on Apogee Therapeutics with a new price target

    Truist initiated coverage of Apogee Therapeutics with a rating of Hold and set a new price target of $83.00

    3/18/26 8:22:50 AM ET
    $APGE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Tandem Diabetes Care upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Tandem Diabetes Care from Neutral to Overweight and set a new price target of $33.00

    3/17/26 7:55:10 AM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    $AIMD
    $AISP
    $ALB
    $APGE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 28, 2025 - FDA Roundup: February 28, 2025

    For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis). Odactra is an allergen extract immunotherapy

    2/28/25 5:00:47 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    November 7, 2023 - FDA Roundup: November 7, 2023

    For Immediate Release: November 07, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA issued a Safety Communication warning consumers, health care providers, and health care facilities not to use recalled saline (0.9% sodium chloride) and sterile water medical products manufactured by Nurse Assist, LLC. On November 6, Nurse

    11/7/23 3:38:18 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    FDA Approval for MYDCOMBI issued to EYENOVIA INC.

    Submission status for EYENOVIA INC.'s drug MYDCOMBI (ORIG-1) with active ingredient TROPICAMIDE AND PHENYLEPHRINE HYDROCHLORIDE has changed to 'Approval' on 05/05/2023. Application Category: NDA, Application Number: 215352, Application Classification: Type 5 - New Formulation or New Manufacturer

    5/8/23 1:05:04 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIMD
    $AISP
    $ALB
    $APGE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Amer Sports Inc.

    SC 13D/A - Amer Sports, Inc. (0001988894) (Subject)

    12/12/24 7:02:15 PM ET
    $AS
    Apparel
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Samsara Inc.

    SC 13D/A - Samsara Inc. (0001642896) (Subject)

    12/11/24 9:27:25 PM ET
    $IOT
    EDP Services
    Technology

    SEC Form SC 13G filed by Paymentus Holdings Inc.

    SC 13G - Paymentus Holdings, Inc. (0001841156) (Subject)

    12/10/24 5:08:45 PM ET
    $PAY
    Real Estate

    $AIMD
    $AISP
    $ALB
    $APGE
    Leadership Updates

    Live Leadership Updates

    View All

    Albemarle Appoints Michelle T. Collins and Mark R. Widmar to Board of Directors

    CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced that its Board of Directors (the "Board") has appointed Michelle T. Collins and Mark R. Widmar to the Board, effective February 26, 2026. Collins will join the Board's Audit & Finance Committee and Governance & Public Policy Committee. Widmar will join the Executive Compensation & Talent Development Committee and Safety, Sustainability, Operations & Capital Committee. Collins brings more t

    3/2/26 4:40:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    AV Announces Retirement of Chief Financial Officer Kevin McDonnell

    AeroVironment, Inc. ("AV" or the "Company") (NASDAQ:AVAV), a global defense technology leader, today announced that Kevin McDonnell, Executive Vice President and Chief Financial Officer, has informed the Company of his decision to retire from AV, effective July 31, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260223105811/en/McDonnell joined AV in 2020. During his tenure as CFO, AV strengthened its balance sheet, enhanced its financial and operational discipline, completed strategic acquisitions and organic growth initiatives, and reinforced its capital allocation framework to drive long-term shareholder value. "Kevin ha

    2/23/26 5:13:00 PM ET
    $AVAV
    Aerospace
    Industrials

    AV Welcomes Stephen Voline as Senior Director, Washington Operations

    Experienced defense policy and government relations leader brings decades of military, legislative, and industry expertise to AV's Washington Operations team AeroVironment, Inc. ("AV") (NASDAQ:AVAV), a global defense technology leader, today announced that Stephen Voline has joined the company as Senior Director of Washington Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211855975/en/Stephen Voline brings more than three decades of experience across military operations, defense policy, and industry advocacy. Voline will support AV's engagement with Congress, the Department of War, and key national security stak

    2/11/26 7:30:00 AM ET
    $AVAV
    Aerospace
    Industrials

    $AIMD
    $AISP
    $ALB
    $APGE
    Financials

    Live finance-specific insights

    View All

    Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026

    SAN FRANCISCO and BOSTON, March 22, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (NASDAQ:APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today announced it will report Part A 52-week data from the Phase 2 APEX trial of zumilokibart on Monday, March 23, 2026. Following the announcement, the company will host a conference call and webcast at 8:00 a.m. ET to discuss the results. Webcast DetailsApogee Therapeutics' live webcast of the Phase 2 APEX Part A results will begin on Monday, March 23rd at 8:00 a.m. ET. The live webcast can be accessed via this l

    3/22/26 7:51:54 PM ET
    $APGE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BitFuFu Announces Unaudited 2025 Full-Year Financial Results

    SINGAPORE, March 20, 2026 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ:FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited financial results for the full year ended December 31, 2025. Full Year 2025 Financial Highlights Total revenue was $475.8 million in 2025, representing an increase of 2.7% from $463.3 million in 2024. The year-over-year increase was driven by higher revenue from Cloud Mining Solutions, Mining Equipment Sales, and Other, partially offset by a decline in revenue from Self-Mining Operations.   For the Year Ended December 31,   2025 2024Business Segment ($ in millions) Revenue % ofRevenue Revenue % of

    3/20/26 6:00:00 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    Yiren Digital Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    BEIJING, March 19, 2026 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced its unaudited financial results for the fourth quarter and 2025 fiscal year ended December 31, 2025. Fourth Quarter and Fiscal Year 2025 Operational HighlightsCredit Solution Business (formerly known as Financial Services Business)Total loans facilitated in the fourth quarter of 2025 was RMB12.0 billion (US$1.7 billion), representing a decrease of 40% compared to RMB20.2 billion in the third quarter of 2025 and a decrease of 22

    3/19/26 7:00:00 AM ET
    $YRD
    Finance: Consumer Services
    Finance